607 related articles for article (PubMed ID: 24998510)
1. New amphotericin B-gamma cyclodextrin formulation for topical use with synergistic activity against diverse fungal species and Leishmania spp.
Ruiz HK; Serrano DR; Dea-Ayuela MA; Bilbao-Ramos PE; Bolás-Fernández F; Torrado JJ; Molero G
Int J Pharm; 2014 Oct; 473(1-2):148-57. PubMed ID: 24998510
[TBL] [Abstract][Full Text] [Related]
2. A novel formulation of solubilised amphotericin B designed for ophthalmic use.
Serrano DR; Ruiz-Saldaña HK; Molero G; Ballesteros MP; Torrado JJ
Int J Pharm; 2012 Nov; 437(1-2):80-2. PubMed ID: 22890190
[TBL] [Abstract][Full Text] [Related]
3. Topical amphotericin B in ultradeformable liposomes: Formulation, skin penetration study, antifungal and antileishmanial activity in vitro.
Perez AP; Altube MJ; Schilrreff P; Apezteguia G; Celes FS; Zacchino S; de Oliveira CI; Romero EL; Morilla MJ
Colloids Surf B Biointerfaces; 2016 Mar; 139():190-8. PubMed ID: 26709977
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of sodium deoxycholate sulfate as a lipid drug carrier to enhance the solubility, stability and safety of an amphotericin B inhalation formulation.
Gangadhar KN; Adhikari K; Srichana T
Int J Pharm; 2014 Aug; 471(1-2):430-8. PubMed ID: 24907597
[TBL] [Abstract][Full Text] [Related]
5. Nanoemulsion gel-based topical delivery of an antifungal drug: in vitro activity and in vivo evaluation.
Hussain A; Samad A; Singh SK; Ahsan MN; Haque MW; Faruk A; Ahmed FJ
Drug Deliv; 2016; 23(2):642-47. PubMed ID: 25013957
[TBL] [Abstract][Full Text] [Related]
6. Formulation and optimization of nanoemulsion using antifungal lipid and surfactant for accentuated topical delivery of Amphotericin B.
Hussain A; Singh VK; Singh OP; Shafaat K; Kumar S; Ahmad FJ
Drug Deliv; 2016 Oct; 23(8):3101-3110. PubMed ID: 27854145
[TBL] [Abstract][Full Text] [Related]
7. Engineering Oral and Parenteral Amorphous Amphotericin B Formulations against Experimental Trypanosoma cruzi Infections.
Rolón M; Serrano DR; Lalatsa A; de Pablo E; Torrado JJ; Ballesteros MP; Healy AM; Vega C; Coronel C; Bolás-Fernández F; Dea-Ayuela MA
Mol Pharm; 2017 Apr; 14(4):1095-1106. PubMed ID: 28198632
[TBL] [Abstract][Full Text] [Related]
8. Amphotericin B formulations: a comparative review of efficacy and toxicity.
Hamill RJ
Drugs; 2013 Jun; 73(9):919-34. PubMed ID: 23729001
[TBL] [Abstract][Full Text] [Related]
9. Permeability Characteristics of a New Antifungal Topical Amphotericin B Formulation with γ-Cyclodextrins.
López-Castillo C; Rodríguez-Fernández C; Córdoba M; Torrado JJ
Molecules; 2018 Dec; 23(12):. PubMed ID: 30567325
[TBL] [Abstract][Full Text] [Related]
10. Amphotericin B-loaded nanoparticles for local treatment of cutaneous leishmaniasis.
Abu Ammar A; Nasereddin A; Ereqat S; Dan-Goor M; Jaffe CL; Zussman E; Abdeen Z
Drug Deliv Transl Res; 2019 Feb; 9(1):76-84. PubMed ID: 30484256
[TBL] [Abstract][Full Text] [Related]
11. Water-soluble amphotericin B-polyvinylpyrrolidone complexes with maintained antifungal activity against Candida spp. and Aspergillus spp. and reduced haemolytic and cytotoxic effects.
Charvalos E; Tzatzarakis MN; Van Bambeke F; Tulkens PM; Tsatsakis AM; Tzanakakis GN; Mingeot-Leclercq MP
J Antimicrob Chemother; 2006 Feb; 57(2):236-44. PubMed ID: 16361329
[TBL] [Abstract][Full Text] [Related]
12. Investigations on feasibility of in situ development of amphotericin B liposomes for industrial applications.
Singodia D; Verma A; Khare P; Dube A; Mitra K; Mishra PR
J Liposome Res; 2012 Mar; 22(1):8-17. PubMed ID: 21682670
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the colloidal properties, in vitro antifungal activity, antileishmanial activity and toxicity in mice of a di-stigma-steryl-hemi-succinoyl-glycero-phosphocholine liposome-intercalated amphotericin B.
Iman M; Huang Z; Szoka FC; Jaafari MR
Int J Pharm; 2011 Apr; 408(1-2):163-72. PubMed ID: 21277963
[TBL] [Abstract][Full Text] [Related]
14. Optimization, stabilization, and characterization of amphotericin B loaded nanostructured lipid carriers for ocular drug delivery.
Lakhani P; Patil A; Wu KW; Sweeney C; Tripathi S; Avula B; Taskar P; Khan S; Majumdar S
Int J Pharm; 2019 Dec; 572():118771. PubMed ID: 31669555
[TBL] [Abstract][Full Text] [Related]
15. Nanoethosomal formulation for skin targeting of amphotericin B: an in vitro and in vivo assessment.
Kaur L; Jain SK; Manhas RK; Sharma D
J Liposome Res; 2015; 25(4):294-307. PubMed ID: 25547800
[TBL] [Abstract][Full Text] [Related]
16. Nanoemulsions loaded with amphotericin B: a new approach for the treatment of leishmaniasis.
Caldeira LR; Fernandes FR; Costa DF; Frézard F; Afonso LC; Ferreira LA
Eur J Pharm Sci; 2015 Apr; 70():125-31. PubMed ID: 25660615
[TBL] [Abstract][Full Text] [Related]
17. In vitro effect of new formulations of amphotericin B on amastigote and promastigote forms of Leishmania infantum.
Ordóñez-Gutiérrez L; Espada-Fernández R; Dea-Ayuela MA; Torrado JJ; Bolás-Fernandez F; Alunda JM
Int J Antimicrob Agents; 2007 Oct; 30(4):325-9. PubMed ID: 17631982
[TBL] [Abstract][Full Text] [Related]
18. Synergistic enhancement of parasiticidal activity of amphotericin B using copaiba oil in nanoemulsified carrier for oral delivery: an approach for non-toxic chemotherapy.
Gupta PK; Jaiswal AK; Asthana S; Teja B V; Shukla P; Shukla M; Sagar N; Dube A; Rath SK; Mishra PR
Br J Pharmacol; 2015 Jul; 172(14):3596-610. PubMed ID: 25825339
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, characterization, and mechanistic studies of a gold nanoparticle-amphotericin B covalent conjugate with enhanced antileishmanial efficacy and reduced cytotoxicity.
Kumar P; Shivam P; Mandal S; Prasanna P; Kumar S; Prasad SR; Kumar A; Das P; Ali V; Singh SK; Mandal D
Int J Nanomedicine; 2019; 14():6073-6101. PubMed ID: 31686803
[TBL] [Abstract][Full Text] [Related]
20. Novel oral amphotericin B formulation (iCo-010) remains highly effective against murine systemic candidiasis following exposure to tropical temperature.
Wasan KM; Sivak O; Bartlett K; Wasan EK; Gershkovich P
Drug Dev Ind Pharm; 2015; 41(9):1425-30. PubMed ID: 25170660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
